Trials / Completed
CompletedNCT02089399
Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers
An Open Label, Randomized, 2-Sequence, Multiple-Dose, Cross-Over Study to Investigate the Drug-Drug Interaction of Sevikar and Crestor in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between amlodipine, olmesartan and rosuvastatin in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevikar(amlodipne/olmesartan) | Treatment AB |
| DRUG | crestor(Rosuvastatin) | Treatment AB/Treatment C |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-03-17
- Last updated
- 2015-04-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02089399. Inclusion in this directory is not an endorsement.